Tristel PLC
12 March 2008
Tristel plc
('Tristel' or 'the Company')
Issue of Equity
Total Voting Rights
Tristel, the AIM listed provider of infection and contamination control
products, announces that it has raised gross funds of GBP1,000,400 to assist
with its continuing product development programme and for working capital
purposes through the placing of 2,440,000 new Ordinary Shares of 1p each, at a
price of 41 pence per share to institutional investors.
Application has been made for the new Ordinary Shares to be admitted to trading
on AIM and these new shares are expected to be admitted on 18th March 2008.
Following the placing, the Company has 26,882,880 Ordinary Shares in issue, all
of which carry voting rights. This figure may be used by shareholders of the
Company as the denominator for the calculations by which they will determine if
they are required to notify their interest in, or change their interest in, the
ordinary share capital of the Company.
Enquiries:
Paul Swinney, Chief Executive
Tristel plc Tel: 01638 721 500
Graham Webster
Daniel Stewart & Company plc Tel: 020 7776 6550
Paul McManus
Parkgreen Communications Ltd Tel: 020 7479 7933
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.